Atossa Genetics (ATOS)
(Delayed Data from NSDQ)
$1.46 USD
-0.06 (-3.95%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $1.48 +0.02 (1.37%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth F Momentum D VGM
Income Statements
Fiscal Year end for Atossa Genetics Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 31 | 28 | 21 | 15 | 17 |
Income After Depreciation & Amortization | -31 | -28 | -21 | -15 | -17 |
Non-Operating Income | 1 | 1 | 0 | -3 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -30 | -27 | -21 | -18 | -17 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -30 | -27 | -21 | -18 | -17 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -30 | -27 | -21 | -18 | -17 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -31 | -28 | -21 | -15 | -17 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -31 | -28 | -21 | -15 | -17 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 126.08 | 126.62 | 116.95 | 11.31 | 8.50 |
Diluted EPS Before Non-Recurring Items | -0.24 | -0.21 | -0.18 | -1.97 | -2.03 |
Diluted Net EPS (GAAP) | -0.24 | -0.21 | -0.18 | -1.97 | -2.03 |
Fiscal Year end for Atossa Genetics Inc falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 7.10 | 6.98 | 9.01 | 7.47 | 7.80 |
Income After SG&A, R&D, and Dept/Amort Expenses | -7.10 | -6.98 | -9.01 | -7.47 | -7.80 |
Non-Operating Income | 1.06 | 1.10 | 1.26 | 1.24 | -2.04 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -6.05 | -5.88 | -7.75 | -6.23 | -9.83 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -6.05 | -5.88 | -7.75 | -6.23 | -9.83 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -6.05 | -5.88 | -7.75 | -6.23 | -9.83 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | 125.73 | 125.32 | 125.60 | 125.79 | 126.62 |
Diluted EPS Before Non-Recurring Items | -0.05 | -0.05 | -0.06 | -0.05 | -0.06 |
Diluted Net EPS (GAAP) | -0.05 | -0.05 | -0.06 | -0.05 | -0.08 |